Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy Naive Prostate Cancer”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Testing effectiveness (Phase 2)UnknownNCT01296243
What this trial is testing

Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Genta Incorporated 57
Testing effectiveness (Phase 2)Study completedNCT00654186
What this trial is testing

Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients

Who this might be right for
Prostate Cancer
Oncology Specialists, S.C. 32
Not applicableStudy completedNCT05968599
What this trial is testing

Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Pfizer 2,731
Large-scale testing (Phase 3)Study completedNCT01591122
What this trial is testing

Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Janssen Research & Development, LLC 313
Testing effectiveness (Phase 2)UnknownNCT00448734
What this trial is testing

Picoplatin and Docetaxel in Subjects With Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Poniard Pharmaceuticals 95
Testing effectiveness (Phase 2)Study completedNCT03204812
What this trial is testing

Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneProstate Adenocarcinoma+3 more
M.D. Anderson Cancer Center 31
Large-scale testing (Phase 3)Study completedNCT01212991
What this trial is testing

A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Pfizer 1,717
Testing effectiveness (Phase 2)Study completedNCT00757692
What this trial is testing

Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer.

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 74
Early research (Phase 1)Study completedNCT00959959
What this trial is testing

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
LTN PHARMACEUTICALS, INC. 49
Testing effectiveness (Phase 2)Study completedNCT00272038
What this trial is testing

Single Agent Erlotinib in Chemotherapy-naive Androgen Independent Prostate Cancer

Who this might be right for
Prostate Cancer
Oncology Specialists, S.C. 29
Testing effectiveness (Phase 2)Study completedNCT02279862
What this trial is testing

Safety and Efficacy Study of Ipilimumab 3 mg/kg Versus Ipilimumab 10 mg/kg in Subjects With Metastatic Castration Resistant Prostate Cancer Who Are Chemotherapy Naive

Who this might be right for
Prostate Cancer
Bristol-Myers Squibb 82
Testing effectiveness (Phase 2)Ended earlyNCT00103428
What this trial is testing

Intravenous CG7870 in Combination With Docetaxel in Patients With Metastatic Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Cell Genesys 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT04343885
What this trial is testing

In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy

Who this might be right for
Metastatic Hormone Naive Prostate Cancer
Peter MacCallum Cancer Centre, Australia 130
Testing effectiveness (Phase 2)Study completedNCT02217566
What this trial is testing

Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 46
Testing effectiveness (Phase 2)Study completedNCT00313781
What this trial is testing

Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)

Who this might be right for
Prostatic Neoplasms
Pfizer 204
Large-scale testing (Phase 3)Study completedNCT00030654
What this trial is testing

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 21
Large-scale testing (Phase 3)Study completedNCT01193244
What this trial is testing

Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 1,560
Early research (Phase 1)Study completedNCT01784757
What this trial is testing

Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Orion Corporation, Orion Pharma 30
Testing effectiveness (Phase 2)Ended earlyNCT04179864
What this trial is testing

Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer

Who this might be right for
Metastatic Prostate CancerMetastatic Castration-resistant Prostate Cancer
Epizyme, Inc. 102
Testing effectiveness (Phase 2)Ended earlyNCT02555189
What this trial is testing

Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaProstate Carcinoma Metastatic in the Bone+1 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 52
Next Page